| CAS登錄號 | 中文名 | 英文名 | 分子結(jié)構(gòu)式 | 分子式 | 詳情 | 供應(yīng)商 |
| 121185-80-6 | L-Phenylalaninamide,L-tyrosyl-L-glutaminyl-L-Leucyl-L-Leucylglycylglycyl-L-arginyl- (9CI); H-TYR-Gln-Leu-Leu-GLY-GLY-ARG-Phe-NH2 |  | C45H69N13O10 | 詳情 | 供應(yīng)商 | |
| 56104-22-4 | Substance P,1-de-L-arginine-2-de-L-proline-3-de-L-lysine-4-de-L-proline-5-(5-oxo-L-proline)-(9CI); GLP-Gln-Phe-Phe-GLY-Leu-MET-NH2; [GLP5] SUBSTANCE P (5-11); PYR-Gln-Phe-Phe-GLY-Leu-MET-NH2; (PYR5)-SUBSTANCE P (5-11); SUBSTANCE P [PGLU5]-FRAGMENT 5-11; PGLU-Gln-Phe-Phe-GLY-Leu-MET-NH2; pglu5-substance P fragment 5-11; Substance P, fragment 5-11, [pGl5] |  | C41H57N9O9S | 詳情 | 供應(yīng)商 | |
| 81381-50-2 | Substance P,1-de-L-arginine-2-de-L-proline-3-de-L-lysine-4-D-alanine- (9CI); D-ALA-Gln-Gln-Phe-Phe-GLY-Leu-MET-NH2; (D-ALA4)-SUBSTANCE P (4-11); H-D-ALA-Gln-Gln-Phe-Phe-GLY-Leu-MET-NH2; SUBSTANCE P OCTAPEPTIDE D-ALA-4-FRAGMENT 4-11); Substance P, fragment 4-11, (D-Ala4) |  | C44H65N11O10S | 詳情 | 供應(yīng)商 | |
| 137061-48-4 | 腺苷酸環(huán)化酶激活肽-38(抗原) | H-HIS-SER-ASP-GLY-ILE-Phe-THR-ASP-SER-TYR-SER-ARG-TYR-ARG-LYS-Gln-MET-ALA-VAL-LYS-LYS-TYR-Leu-ALA-AL; H-HIS-SER-ASP-GLY-ILE-Phe-THR-ASP-SER-TYR-SER-ARG-TYR-ARG-LYS-Gln-MET-ALA-VAL-LYS-LYS-TYR-Leu-ALA-ALA-VAL-Leu-GLY-LYS-ARG-TYR-LYS-Gln-ARG-VAL-LYS-ASN-LYS-NH2; HIS-SER-ASP-GLY-ILE-Phe-THR-ASP-SER-TYR-SER-ARG-TYR-ARG-LYS-Gln-MET-ALA-VAL-LYS-LYS-TYR-Leu-ALA-ALA-VAL-Leu-GLY-LYS-ARG-TYR-LYS-Gln-ARG-VAL-LYS-ASN-LYS-NH2; HSDGIFTDSYSRYRKQMAVKKYLAAVLGKRYKQRVKNK-NH2; ADENYLATE CYCLASE ACTIVATING PEPTIDE-38; ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE-38; PACAP (1-38), AMIDE, HUMAN, OVINE, RAT; PACAP (1-38), HUMAN, OVINE, RAT; PACAP (1-38) (HUMAN, SHEEP, RAT) | 無 | C203H331N63O53S1 | 詳情 | 供應(yīng)商 |
| 866552-34-3 | HIS-ALA-ASP-ALA-VAL-Phe-THR-ALA-ALA-TYR-ALA-ARG-Leu-ARG-LYS-Gln-MET-ALA-ALA-LYS-LYS-ALA-Leu-ALA-ALA-; [ALA2,8,9,11,19,22,24,25,27,28]-VIP; HIS-ALA-ASP-ALA-VAL-Phe-THR-ALA-ALA-TYR-ALA-ARG-Leu-ARG-LYS-Gln-MET-ALA-ALA-LYS-LYS-ALA-Leu-ALA-ALA-ILE-ALA-ALA-NH2 |  | C131H219N41O33S | 詳情 | 供應(yīng)商 | |
| 152286-31-2 | TYR-GLU-VAL-HIS-HIS-Gln-LYS-Leu-VAL-Phe-Phe | H-TYR-GLU-VAL-HIS-HIS-Gln-LYS-Leu-VAL-Phe-Phe-OH; AMYLOID BETA-PROTEIN (10-20); AMYLOID BETA-PEPTIDE (10-20) (HUMAN); AMYLOID BETA-PROTEIN FRAGMENT 10-20; H-TYR-GLU-VAL-HIS-HIS-Gln-LYS-Leu-VAL-Phe-Phe-OH; BETA-AMYLOID (10-20); YEVHHQKLVFF; TYR-GLU-VAL-HIS-HIS-Gln-LYS-Leu-VAL-Phe-Phe; amyloid B-protein fragment 10-20 |  | C71H99N17O16 | 詳情 | 供應(yīng)商 |
| 107015-83-8 | 淀粉-Β-蛋白片段12-28 | H-VAL-HIS-HIS-Gln-LYS-Leu-VAL-Phe-Phe-ALA-GLU-ASP-VAL-GLY-SER-ASN-LYS-OH; H-VAL-HIS-HIS-Gln-LYS-Leu-VAL-Phe-Phe-ALA-GLU-ASP-VAL-GLY-SER-ASN-LYS-OH; BETA-AMYLOID (12-28); BETA-AMYLOID PEPTIDE [12-28], HUMAN; ALZHEIMER'S DISEASE BETA-PROTEIN (12-28); AMYLOID, BETA- (12-28), HUMAN; AMYLOID BETA-PROTEIN (12-28); AMYLOID-BETA PROTEIN (12-28), HUMAN; AMYLOID BETA-PROTEIN FRAGMENT 12-28 |  | C89H135N25O25 | 詳情 | 供應(yīng)商 |
| 166090-74-0 | H-DAEFRHDSGYEVHHQKLVFFAEDVGSNKGAIIGLMVGGVVIA-OH | H-ASP-ALA-GLU-Phe-ARG-HIS-ASP-SER-GLY-TYR-GLU-VAL-HIS-HIS-Gln-LYS-Leu-VAL-Phe-Phe-ALA-GLU-ASP-VAL-GL; PREDOMINANT AMYLOID B-PROTEIN FRAGMENT; ASP-ALA-GLU-Phe-ARG-HIS-ASP-SER-GLY-TYR-GLU-VAL-HIS-HIS-Gln-LYS-Leu-VAL-Phe-Phe-ALA-GLU-ASP-VAL-GLY-SER-ASN-LYS-GLY-ALA-ILE-ILE-GLY-Leu-MET-VAL-GLY-GLY-VAL-VAL-ILE-ALA; ASP-ALA-GLU-Phe-GLY-HIS-ASP-SER-GLY-Phe-GLU-VAL-ARG-HIS-Gln-LYS-Leu-VAL-Phe-Phe-ALA-GLU-ASP-VAL-GLY-SER-ASN-LYS-GLY-ALA-ILE-ILE-GLY-Leu-MET-VAL-GLY-GLY-VAL-VAL-ILE-ALA; BAP 1-42; BETA-AMYLOID, SODIUM SALT; BETA-AMYLOID PEPTIDE (1-40), MOUSE, RAT; BETA-AMYLOID PEPTIDE (1-40), RAT; BETA-AMYLOID PEPTIDE (1-42), RAT | 無 | C203H311N55O60S | 詳情 | 供應(yīng)商 |
| 230299-95-3 | Leu-VAL-LYS-PRO-ARG-THR-SER-ARG-THR-GLY-PRO-GLY-ALA-TRP-Gln-GLY-GLY-ARG-ARG-LYS-Phe-ARG-ARG-Gln-ARG-; APELIN-36, MOUSE, RAT; APELIN-36 (RAT, MOUSE); Leu-VAL-LYS-PRO-ARG-THR-SER-ARG-THR-GLY-PRO-GLY-ALA-TRP-Gln-GLY-GLY-ARG-ARG-LYS-Phe-ARG-ARG-Gln-ARG-PRO-ARG-Leu-SER-HIS-LYS-GLY-PRO-MET-PRO-Phe; Leu-VAL-LYS-PRO-ARG-THR-SER-ARG-THR-GLY-PRO-GLY-ALA-TRP-Gln-GLY-GLY-ARG-ARG-LYS-Phe-ARG-ARG-Gln-ARG-PRO-ARG-Leu-SER-HIS-LYS-GLY-PRO-MET-PRO-Phe |  | C185H304N68O43S | 詳情 | 供應(yīng)商 | |
| 96736-12-8 | (D-ARG1,D-Phe5,D-TRP7·9,Leu11)-SUBSTANCE P | D-ARG-PRO-LYS-PRO-D-Phe-Gln-D-TRP-Phe-D-TRP-Leu-Leu-NH2; [D-ARG1, D-Phe5, D-TRP7,9, Leu11]-SUBSTANCE P; D-ARG-PRO-LYS-PRO-D-Phe-Gln-D-TRP-Phe-D-TRP-Leu-Leu-NH2; H-D-ARG-PRO-LYS-PRO-D-Phe-Gln-D-TRP-Phe-D-TRP-Leu-Leu-NH2; substance P, Phe(5)-Trp(7,9)-Leu(11)-; Substance P, [D-Arg1, D-Phe5, D-Trp7,9, Leu11]; AntagonistD, D-Arg-Pro-Lys-Pro-D-Phe-Gln-D-Trp-Phe-D-Trp-Leu-Leu-NH2; M.W. 1516.85 C79H109N19O12; D-Arg-L-Pro-L-Lys-L-Pro-D-Phe-L-Gln-D-Trp-L-Phe-D-Trp-L-Leu-L-Leu-NH2 |  | C79H109N19O12 | 詳情 | 供應(yīng)商 |
| 90984-99-9 | ARG-ARG-SER-SER-CYS-Phe-GLY-GLY-ARG-ILE-ASP-ARG-ILE-GLY-ALA-Gln-SER-GLY-Leu-GLY-CYS-ASN-SER-Phe-ARG- | ARG-ARG-SER-SER-CYS-Phe-GLY-GLY-ARG-ILE-ASP-ARG-ILE-GLY-ALA-Gln-SER-GLY-Leu-GLY-CYS-ASN-SER-Phe-ARG-; H-ARG-ARG-SER-SER-CYS-Phe-GLY-GLY-ARG-ILE-ASP-ARG-ILE-GLY-ALA-Gln-SER-GLY-Leu-GLY-CYS-ASN-SER-Phe-ARG-TYR-OH; ATRIAL NATRIURETIC PEPTIDE RAT FRAGMENT 3-28; ATRIAL NATRIURETIC FACTOR (3-28) (RAT); ATRIAL NATRIURETIC PEPTIDE (3-28), RAT; A-TYPE (ATRIAL) NATRIURETIC PEPTIDE (RAT, 3-28); ARG-ARG-SER-SER-CYS-Phe-GLY-GLY-ARG-ILE-ASP-ARG-ILE-GLY-ALA-Gln-SER-GLY-Leu-GLY-CYS-ASN-SER-Phe-ARG-TYR; ANP (RAT, 3-28); ANP (3-28), RAT |  | C119H189N43O36S2 | 詳情 | 供應(yīng)商 |
| 313951-59-6 | (DES-OCTANOYL)-GHRELIN (HUMAN) | H-GLY-SER-SER-Phe-Leu-SER-PRO-GLU-HIS-Gln-ARG-VAL-Gln-Gln-ARG-LYS-GLU-SER-LYS-LYS-PRO-PRO-ALA-LYS-LE; GSSFLSPEHQRVQQRKESKKPPAKLQPR; GLY-SER-SER-Phe-Leu-SER-PRO-GLU-HIS-Gln-ARG-VAL-Gln-Gln-ARG-LYS-GLU-SER-LYS-LYS-PRO-PRO-ALA-LYS-Leu-Gln-PRO-ARG; H-GLY-SER-SER-Phe-Leu-SER-PRO-GLU-HIS-Gln-ARG-VAL-Gln-Gln-ARG-LYS-GLU-SER-LYS-LYS-PRO-PRO-ALA-LYS-Leu-Gln-PRO-ARG-OH; (DES-OCTANOYL)-GHRELIN (HUMAN); H-Gly-Ser-Ser-Phe-Leu-Ser-Pro-Glu-His-Gln-Arg-Val-Gln-Gln-Arg-Lys-Glu-Ser-Lys-Lys-Pro-Pro-Ala-Lys-Leu-Gln-Pro-Arg-OH; M.W. 3244.51 C141H235N47O41 |  | C141H235N47O41 | 詳情 | 供應(yīng)商 |
| 860790-38-1 | GLY-TRP-THR-Leu-ASN-SER-ALA-GLY-TYR-Leu-Leu-GLY-PRO-Gln-PRO-PRO-GLY-Phe-SER-PRO-Phe-ARG-NH2; GLY-TRP-THR-Leu-ASN-SER-ALA-GLY-TYR-Leu-Leu-GLY-PRO-Gln-PRO-PRO-GLY-Phe-SER-PRO-Phe-ARG-NH2; M617 |  | C112H161N29O28 | 詳情 | 供應(yīng)商 | |
| 208041-90-1 | ARG-SER-ARG-THR-ARG-Gln-Phe-TYR-GLY-Leu-MET-NH2 | H-ARG-SER-ARG-THR-ARG-Gln-Phe-TYR-GLY-Leu-MET-NH2; HK-1, MOUSE; HK-1 (MOUSE, RAT); H-ARG-SER-ARG-THR-ARG-Gln-Phe-TYR-GLY-Leu-MET-NH2; H2N-RSRTRQFYGLM-AMIDE; HEMOKININ 1 (MOUSE); HEMOKININ 1 (MOUSE, RAT); HEK-1, MOUSE; HEK-1 (MOUSE, RAT) |  | C61H100N22O15S | 詳情 | 供應(yīng)商 |
| 192387-39-6 | NEUROPEPTIDE SF (HUMAN) | NEUROPEPTIDE SF (HUMAN); H-SER-Gln-ALA-Phe-Leu-Phe-Gln-PRO-Gln-ARG-Phe-NH2; NEUROPEPTIDE SF (HUMAN); Dalargin(wound healing peptide: Afonskaya N.I. Bull.Exp.Biol.Med. 12, 754, 1986) |  | C65H94N18O15 | 詳情 | 供應(yīng)商 |
| 143748-18-9 | PACAP (6-38), HUMAN, OVINE, RAT | H-Phe-THR-ASP-SER-TYR-SER-ARG-TYR-ARG-LYS-Gln-MET-ALA-VAL-LYS-LYS-TYR-Leu-ALA-ALA-VAL-Leu-GLY-LYS-AR; FTDSYSRYRKQMAVKKYLAAVLGKRYKQRVKNK-NH2; HIS-SER-ASP-GLY-ILE-Phe-THR-AP-SER-TYR-SER-ARG-TYR-ARG-LYS-Gln-MET-ALA-VAL-LYS-LYS-TYR-Leu-ALA-ALA-VAL-Leu-GLY-LYS-ARG-TYR-LYS-Gln-ARG-VAL-LYS-ASN-LYS-NH2; H-Phe-THR-ASP-SER-TYR-SER-ARG-TYR-ARG-LYS-Gln-MET-ALA-VAL-LYS-LYS-TYR-Leu-ALA-ALA-VAL-Leu-GLY-LYS-ARG-TYR-LYS-Gln-ARG-VAL-LYS-ASN-LYS-NH2; Phe-THR-ASP-SER-TYR-SER-ARG-TYR-ARG-LYS-Gln-MET-ALA-VAL-LYS-LYS-TYR-Leu-ALA-ALA-VAL-Leu-GLY-LYS-ARG-TYR-LYS-Gln-ARG-VAL-LYS-ASN-LYS-NH2; PITUITARY ADENYLATE ACTIVATING POLYPEPTIDE (6-38) (HUMAN, OVINE, RAT); PITUITARY ADENYLATE CYCLASE ACTIVATING PEPTIDE (6-38), HUMAN, OVINE, RAT; PITUITARY ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE-38 (6-38) (HUMAN, CHICKEN, MOUSE, OVINE, PORCINE, RAT); PITUITARY ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE (6-38) AMIDE (HUMAN, OVINE, RAT) |  | C203H331N63O65S | 詳情 | 供應(yīng)商 |
| 108437-88-3 | (D-Phe12,Leu14)-BOMBESIN | PYR-Gln-ARG-Leu-GLY-ASN-Gln-TRP-ALA-VAL-GLY-D-Phe-Leu-Leu-NH2; (D-Phe12,Leu14)-BOMBESIN; GLP-Gln-ARG-Leu-GLY-ASN-Gln-TRP-ALA-VAL-GLY-DPhe-Leu-Leu-NH2; PGLU-Gln-ARG-Leu-GLY-ASN-Gln-TRP-ALA-VAL-GLY-D-Phe-Leu-Leu-NH2; PYR-QRLGNQWAVGFLL-NH2; PYR-Gln-ARG-Leu-GLY-ASN-Gln-TRP-ALA-VAL-GLY-D-Phe-Leu-Leu-NH2; bombesin, Phe(12), Leu(14)- |  | C75H114N22O18 | 詳情 | 供應(yīng)商 |
| 122613-29-0 | Leu-Leu-TYR-GLU-MET-Leu-ALA-GLY-Gln-ALA-PRO-Phe-GLU-GLY-GLU-ASP-GLU-ASP-GLU-Leu-Phe-Gln-SER-ILE-MET- | H-Leu-Leu-TYR-GLU-MET-Leu-ALA-GLY-Gln-ALA-PRO-Phe-GLU-GLY-GLU-ASP-GLU-ASP-GLU-Leu-Phe-Gln-SER-ILE-ME; PKC (530-558); PKC FRAGMENT (530-558); PROTEIN KINASE C (530-558); PROTEIN KINASE C FRAGMENT 530-558; LLYEMLAGQAPFEGEDEDELFQSIMEHNV; LLYEMLAGQAPFEGEDEDELFQSIMEHNV-NH2; H-Leu-Leu-TYR-GLU-MET-Leu-ALA-GLY-Gln-ALA-PRO-Phe-GLU-GLY-GLU-ASP-GLU-ASP-GLU-Leu-Phe-Gln-SER-ILE-MET-GLU-HIS-ASN-VAL-NH2; H-Leu-Leu-TYR-GLU-MET-Leu-ALA-GLY-Gln-ALA-PRO-Phe-GLU-GLY-GLU-ASP-GLU-ASP-GLU-Leu-Phe-Gln-SER-ILE-MET-GLU-HIS-ASN-VAL-NH2 |  | C148H221N35O50S2 | 詳情 | 供應(yīng)商 |
| 126738-34-9 | CYS-SER-CYS-LYS-ASP-MET-THR-ASP-LYS-GLU-CYS-Leu-ASN-Phe-CYS-HIS-Gln-ASP-VAL-ILE-TRP (DISULFIDE BRIDG | H-CYS-SER-CYS-LYS-ASP-MET-THR-ASP-LYS-GLU-CYS-Leu-ASN-Phe-CYS-HIS-Gln-ASP-VAL-ILE-TRP-OH; SARAFOTOXIN A; SARAFOTOXIN A (ATRACTASPIS ENGADDENSIS); SARAFOTOXIN S6A; SARAFOTOXIN S6A1; SARAFOTOXIN S6A (ATRACTASPIS ENGADDENSIS); H-CYS-SER-CYS-LYS-ASP-MET-THR-ASP-LYS-GLU-CYS-Leu-ASN-Phe-CYS-HIS-Gln-ASP-VAL-ILE-TRP-OH; CYS-SER-CYS-LYS-ASP-MET-THR-ASP-LYS-GLU-CYS-Leu-ASN-Phe-CYS-HIS-Gln-ASP-VAL-ILE-TRP; M.W. 2514.85 C105H156N28O34S5 |  | C105H156N28O34S5 | 詳情 | 供應(yīng)商 |
| 117592-22-0 | THR-Phe-Gln-ALA-TYR-PRO-Leu-ARG-GLU-ALA: TFQAYPLREA; THR-Phe-Gln-ALA-TYR-PRO-Leu-ARG-GLU-ALA: TFQAYPL | THR-Phe-Gln-ALA-TYR-PRO-Leu-ARG-GLU-ALA; RETROVIRAL PROTEASE SUBSTRATE; THR-Phe-Gln-ALA-TYR-PRO-Leu-ARG-GLU-ALA; T-F-Q-A-Y-P-L-R-E-A; H-THR-Phe-Gln-ALA-TYR-PRO-Leu-ARG-GLU-ALA-OH |  | C55H82N14O16 | 詳情 | 供應(yīng)商 |